RxDoctor Payments Data

Lee Walker, MD

Internal Medicine · Little Rock, ARNPI 1417044348

Payments from drug & device makers

$1,023in general payments, 2019–2025

Across 57 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$206
  • AstraZeneca$146
  • Abbott$144
  • Getinge USA Sales, LLC$70
  • Kowa Pharmaceuticals America, Inc.$69
  • Novartis$60
  • plus $329 from 13 others

What the payments were for

  • Food & beverage$1,023100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,023 in reported general payments places this provider in the 70th percentile of 614 internal medicine providers in Arkansas.

See all internal medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$115,741
Medicare patients
244
Services billed
1,741

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban67$69,085
JardianceEmpagliflozin52$58,591
XareltoRivaroxaban33$30,322
LinzessLinaclotide24$26,934
RybelsusSemaglutide28$26,323
JanuviaSitagliptin Phosphate38$24,393
TradjentaLinagliptin11$16,003
FarxigaDapagliflozin Propanediol17$12,874
VascepaIcosapent Ethyl32$11,564
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,313
Omeprazole290$5,221
Atorvastatin Calcium685$4,193
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$3,928
Potassium Chloride221$3,046
Colchicine46$2,864

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$28$74,59563 claims
PfizerEliquis$206$69,08567 claims
Johnson & JohnsonXarelto$20$30,32233 claims
AbbVieLinzess, Synthroid$28$28,57546 claims
AstraZenecaFarxiga$146$12,87417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 614 internal medicine providers in Arkansas.

Other internal medicine in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →